Astrocytoma, Grade II
specificIDH-mutant astrocytoma characterized by the presence of well-differentiated fibrillary glial cells diffusely infiltrating the central nervous system.
6
Centers
0
Active Trials
—
Cancer Funding
Top Centers for Astrocytoma, Grade II(6)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive | 58.3 |
| 2 | Moffitt Cancer CenterTampa, FL NCI Comprehensive | 58.3 |
| 3 | University of Illinois Cancer CenterChicago, IL | 58.3 |
| 4 | Cancer Center at IllinoisUrbana, IL | 58.3 |
| 5 | University of Cincinnati Cancer CenterCincinnati, OH | 58.3 |
| 6 | University of Texas Medical Branch Cancer CenterGalveston, TX | 58.3 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →